MedPath

Does Sildenafil Increase Exercise Performance in Air Pollution?

Not Applicable
Completed
Conditions
Pulmonary Hypertension
Pulmonary Artery Pressure
Exercise Performance
Air Pollution
Interventions
Other: placebo
Registration Number
NCT00808912
Lead Sponsor
Marywood University
Brief Summary

The purpose of this study is to examine if the ingestion of a standard dose of sildenafil enhances the athletic performance of competitive athletes when exercising in a high pollutant environment verses a low air pollutant environment.

Detailed Description

This study will evaluate effects of sildenafil on exercise performance while breathing high levels of emission exhaust ultrafine and fine particulate matter. Exercise performance will be measured by work accumulation (total kJ) during a 6-min maximal effort cycle ergometer ride (CER) done immediately after 30 min cycling at 75% of 6 min mean watts determined from familiarization trial. Peak oxygen consumption, cardiac output, pulmonary artery pressure, diffusion capacity(DLco), and SaO2 will be determined for each trial. Blood and urine will be analyzed for sildenafil using LC/MS.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
24
Inclusion Criteria
  • non-asthmatic
  • asthmatic
  • active participants in endurance sports.
Exclusion Criteria
  • history of high blood pressure
  • history of heart disease
  • pulmonary arterial hypertension
  • pulmonary emboli
  • diagnosis of moderate to severe asthma (FEV1 <75% predicted)
  • pregnant or lactating

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1sildenafilSubjects will exercise in a high air pollutant environment after ingesting a standard dose of sildenafil.
2sildenafilSubjects will exercise in a low pollutant environment after ingesting a standard dose of sildenafil.
3placeboSubjects will exercise in a high pollutant environment after ingesting a placebo.
4placeboSubjects will exercise in a low pollutant environment after ingesting a placebo.
Primary Outcome Measures
NameTimeMethod
That a decrease in exercise performance subsequent to emissions particle inhalation will be blunted by oral ingestion of 50 mg sildenafil prior to a 6-min maximal accumulation test (total kJ)on a cycle ergometer.Cycle ergometer testing will be done one hour after administration of sildenafil or matching placebo.
Secondary Outcome Measures
NameTimeMethod
That the decreased VO2 peak and decreased exercise performance from emissions inhalation will be the result of pulmonary hypertension causing decreased stroke volume.Pulmonary artery pressure will be measured before and immediately post exercise.
That plasma and urine sildenafil and metabolites will be measurable by liquid chromatography mass spectrometry (LC/MS) 6 h post ingestion.Blood and urine samples will be collected at 1, 3, 1nd 6 hours post exercise testing.

Trial Locations

Locations (1)

Marywood University

🇺🇸

Scranton, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath